COA #80175 matches Janoshik Labs's public record. So this test doesn't rest on our review alone — the lab confirms it too.
KHQDFI5X8UZJNot on file for this certificate: endotoxins, sterility and heavy metals. A purity figure says nothing about those.
Label 50 mg · Lab measured 54.21 mg
108% of label, basis not stated — shown as printed. Reconstituted with 2 mL, a 50-unit draw holds 13.6 mg using the measured mass, against 12.5 mg on the label — 8% more.
One vial from this lot was weighed by the laboratory, not yours. This page reports what the certificate says; it does not recommend a dose.
| Report number | #80175 |
|---|---|
| Portal lookup | ✓ Lab-verified |
| Checked | 24 Jul 2026date taken from the record, not from a logged check |
| Checked by | Peptigrity staff, against the lab's portal |
| PDF vs portal | Janoshik Labs's portal shows validity only |
| Weight | Counts as one lab test |
Independent HPLC purity analysis of GHK-Cu from Uther, performed by Janoshik Labs on September 25, 2025. Reported purity: 99.934%. Net content: 54.21 mg against 50 mg labeled (108% of label). Batch HK500917. Sample source: shop-provided. Certificate of analysis attached.
| Lot | Tested | Lab | Purity | vs label | Status |
|---|---|---|---|---|---|
| HK100-0523 | 10 Jun 2026 | Uzorak | 99.68% | 127% | Unverified |
| HK100-0517 | 2 Jun 2026 | Uzorak | 99.87% | 122% | Unverified |
| HK50-0517 | 2 Jun 2026 | Uzorak | 99.63% | 115% | Unverified |
| HK100-0302 | 10 Apr 2026 | Janoshik Labs | 99.757% | 117% | Unverified |
| HK50-0324 | 10 Apr 2026 | Janoshik Labs | 99.766% | 121% | Unverified |
| HK100-0322 | 9 Apr 2026 | Janoshik Labs | 99.773% | 117% | Unverified |
| HK50-0312 | 27 Mar 2026 | Janoshik Labs | 99.835% | 124% | Unverified |
| HK50-0304 | 18 Mar 2026 | Janoshik Labs | 99.78% | 120% | Unverified |
Batches this shop has published a certificate for, newest first. A lot whose printed value cannot identify a batch is not listed.
Submit your third-party lab test to help the community verify purity claims. Every report is reviewed before publication.
Community discussion